Kenneth Krogulski - 01 Nov 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
01 Nov 2023
Transactions value $
$5,369
Form type
4
Filing time
17 Nov 2023, 17:02:56 UTC
Previous filing
03 Nov 2023
Next filing
06 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $518 +280 +0.12% $1.85 225,287 01 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $552 +280 +0.12% $1.97 225,567 02 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $577 +280 +0.12% $2.06 225,847 03 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $568 +280 +0.12% $2.03 226,127 06 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $193 +96 +0.04% $2.01 226,223 07 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $560 +280 +0.12% $2.00 226,503 08 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $510 +280 +0.12% $1.82 226,783 09 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $496 +280 +0.12% $1.77 227,063 10 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $413 +236 +0.1% $1.75 227,299 13 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $484 +280 +0.12% $1.73 227,579 14 Nov 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $498 +280 +0.12% $1.78 227,859 15 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.